JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB55178

Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1]

4

(1 Review)

|

(22 Publications)

Mouse Monoclonal FOXA1 antibody. Carrier free. Suitable for Flow Cyt, WB, ICC/IF, IHC-P and reacts with Human, Recombinant fragment - Human samples. Cited in 22 publications. Immunogen corresponding to Recombinant Fragment Protein within Human FOXA1 aa 350 to C-terminus.

View Alternative Names

HNF3A, TCF3A, FOXA1, Hepatocyte nuclear factor 3-alpha, HNF-3-alpha, HNF-3A, Forkhead box protein A1, Transcription factor 3A, TCF-3A

6 Images
Immunocytochemistry/ Immunofluorescence - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)

ab55178 at 10 ug/ml staining FOXA1 in human HepG2 cells by Immunocytochemistry/ Immunofluorescence.

This image was generated using the ascites version of the product.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)

FOXA1 antibody (ab55178) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human salivary gland.

This image was generated using the ascites version of the product.

Flow Cytometry - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)

Overlay histogram showing HepG2 cells stained with ab55178 (red line). The cells were fixed with 4 % paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab55178, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed.
This image was generated using the ascites version of the product.

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
  • WB

Lab

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)

Lanes 1- 2 : Merged signal (red and green). Green - ab55178 observed at 49 kDa. Red - Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) observed at 37 kDa.

ab55178 was shown to react with FOXA1 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261823 (knockout cell lysate ab256920) was used. Wild-type HeLa and FOXA1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab55178 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) overnight at 4°C at a 1 in 500 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye®800CW) preadsorbed (ab216772) and Goat Anti-Rabbit IgG H&L (IRDye®680RD) preadsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

HeLa cells are predicted to express FOXA1, with no expression of FOXA2 or FOXA3.

All lanes:

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (ab55178) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

FOXA1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human FOXA1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-foxa1-knockout-hela-cell-line-ab261823'>ab261823</a>)

Predicted band size: 49 kDa

Observed band size: 49 kDa

false

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
  • WB

Unknown

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)

FOXA1 antibody (ab55178) at 1ug/lane + HepG2 cell lysate at 25ug/lane.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (ab55178)

Predicted band size: 49 kDa

false

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
  • WB

Lab

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)

Western blot : Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] ab55178 staining at 1/500 dilution, shown in green; Rabbit anti GST (ab111947) loading control staining at 1/200 dilution, shown in magenta. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (ab55178) at 1/500 dilution

Lane 1:

FOXA1 Recombinant Protein at 0.1 µg

Lane 2:

FOXA2 Recombinant Protein at 0.1 µg

Lane 3:

FOXA3 Recombinant Protein at 0.1 µg

Secondary

All lanes:

Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20000 dilution

Predicted band size: 52 kDa,50 kDa,37 kDa

Observed band size: 78 kDa,76 kDa,63 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

1B1

Isotype

IgG2a

Light chain type

kappa

Carrier free

Yes

Reacts with

Human

Applications

IHC-P, Flow Cyt, WB, ICC/IF

applications

Immunogen

Recombinant Fragment Protein within Human FOXA1 aa 350 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P55317

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2c-kappa-monoclonal-18c8bc7ad10-isotype-control-ab170191'>ab170191</a> - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Recombinant fragment - Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 24/1/19. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Purified from TCS.
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FOXA1 also known as Forkhead Box A1 is a transcription factor with a molecular weight of about 49 kDa. It plays a role by binding to specific DNA sequences influencing the expression of genes involved in various cellular processes. This protein is expressed in tissues like liver lungs and prostate. Researchers also refer to FOXA1 as HNF-3α emphasizing its importance in transcription regulation.
Biological function summary

FOXA1 influences the transcriptional control of genes essential for organ development and metabolic regulation. It acts as a pioneer factor opening chromatin structure to enable access for other transcription factors. FOXA1 integrates into complexes that involve histone modification affecting the chromatin state and transcription of target genes. This function is necessary for the proper differentiation and function of several tissues.

Pathways

FOXA1 participates significantly in the androgen receptor signaling pathway and the estrogen receptor signaling pathway. It interacts closely with androgen receptor facilitating the expression of genes that influence cell growth and proliferation. The involvement of FOXA1 in these pathways highlights its critical role in pathways that regulate hormone-responsive cancers and metabolic processes.

FOXA1 shows a strong association with cancers such as prostate cancer and breast cancer. FOXA1's interaction with the androgen receptor links it to prostate cancer progression while its involvement with the estrogen receptor correlates with breast cancer development. Aberrations in its expression or function can disrupt these pathways emphasizing the importance of FOXA1 in cancer biology and its potential as a therapeutic target.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor that is involved in embryonic development, establishment of tissue-specific gene expression and regulation of gene expression in differentiated tissues. Is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites. Binds DNA with the consensus sequence 5'-[AC]A[AT]T[AG]TT[GT][AG][CT]T[CT]-3' (By similarity). Proposed to play a role in translating the epigenetic signatures into cell type-specific enhancer-driven transcriptional programs. Its differential recruitment to chromatin is dependent on distribution of histone H3 methylated at 'Lys-5' (H3K4me2) in estrogen-regulated genes. Involved in the development of multiple endoderm-derived organ systems such as liver, pancreas, lung and prostate; FOXA1 and FOXA2 seem to have at least in part redundant roles (By similarity). Modulates the transcriptional activity of nuclear hormone receptors. Is involved in ESR1-mediated transcription; required for ESR1 binding to the NKX2-1 promoter in breast cancer cells; binds to the RPRM promoter and is required for the estrogen-induced repression of RPRM. Involved in regulation of apoptosis by inhibiting the expression of BCL2. Involved in cell cycle regulation by activating expression of CDKN1B, alone or in conjunction with BRCA1. Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis.
See full target information FOXA1

Additional targets

FOXA2,FOXA3

Publications (22)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 26: PubMed40724920

2025

Long-Term Hypoxia Upregulates Wnt and TGFβ1 Signaling in Eccrine Sweat Gland Cells In Vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Yanlin Lyu,Hiroko Kato,Qianwen Luo,Naoya Otani,Tateki Kubo,Kiyotoshi Sekiguchi,Fumitaka Fujita

NPJ precision oncology 9:127 PubMed40319192

2025

FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenda Wang,Abudurexiti Mierxiati,Wenkai Zhu,Tian Li,Hua Xu,Fangning Wan,Dingwei Ye

EMBO reports 26:443-469 PubMed39633177

2024

Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Dario De Felice,Alessandro Alaimo,Davide Bressan,Sacha Genovesi,Elisa Marmocchi,Nicole Annesi,Giulia Beccaceci,Davide Dalfovo,Federico Cutrupi,Stefano Medaglia,Veronica Foletto,Marco Lorenzoni,Francesco Gandolfi,Srinivasaraghavan Kannan,Chandra S Verma,Alessandro Vasciaveo,Michael M Shen,Alessandro Romanel,Fulvio Chiacchiera,Francesco Cambuli,Andrea Lunardi

Annals of surgery open : perspectives of surgical history, education, and clinical approaches 5:e385 PubMed38883957

2024

Neoadjuvant Chemoradiotherapy Upregulates the Immunogenicity of Cold to Hot Tumors in Esophageal Cancer Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Yushi Nagaki,Satoru Motoyama,Yusuke Sato,Akiyuki Wakita,Hiromu Fujita,Kohei Kemuriyama,Ryohei Sasamori,Shu Nozaki,Kyoko Nomura,Yoshihiro Minamiya

Translational oncology 39:101807 PubMed38235618

2024

MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Fanchang Zeng,Daoyuan Li,Xinli Kang,Qinghui Wu,Mi Song,Zhewen Ou,Zuobing Yang,Jing Yang,Liumei Luo

Molecular cell 84:476-489.e10 PubMed38211589

2024

Pioneer and PRDM transcription factors coordinate bivalent epigenetic states to safeguard cell fate.

Applications

Unspecified application

Species

Unspecified reactive species

Satoshi Matsui,Marissa Granitto,Morgan Buckley,Katie Ludwig,Sandra Koigi,Joseph Shiley,William J Zacharias,Christopher N Mayhew,Hee-Woong Lim,Makiko Iwafuchi

Frontiers in oncology 13:1120329 PubMed36816919

2023

Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Shruti D Shah,Bryan M Gillard,Michelle M Wrobel,Ellen Karasik,Michael T Moser,Michalis Mastri,Mark D Long,Norbert Sule,Craig M Brackett,Wendy J Huss,Barbara A Foster

Computational and mathematical methods in medicine 2022:3110330 PubMed36003920

2022

miR-29b Regulates Lung Cancer Progression by Downregulating FEM1B and Inhibiting the FOX01/AKT Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Huanrong Zhang,Rong Wang,Qiuhua Deng

Nature communications 12:6636 PubMed34789735

2021

Sequence logic at enhancers governs a dual mechanism of endodermal organ fate induction by FOXA pioneer factors.

Applications

Unspecified application

Species

Unspecified reactive species

Ryan J Geusz,Allen Wang,Dieter K Lam,Nicholas K Vinckier,Konstantinos-Dionysios Alysandratos,David A Roberts,Jinzhao Wang,Samy Kefalopoulou,Araceli Ramirez,Yunjiang Qiu,Joshua Chiou,Kyle J Gaulton,Bing Ren,Darrell N Kotton,Maike Sander

Environmental toxicology 36:2093-2104 PubMed34254728

2021

Long noncoding RNA LINC01287 promotes proliferation and inhibits apoptosis of lung adenocarcinoma cells via the miR-3529-5p/RNASEH2A axis under the competitive endogenous RNA pattern.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Zhang,Dan Ma,Honggang Kang,Jun Zhao,Mengxiang Yang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com